Source-grounded facts extracted from abrdn World Healthcare Fund's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
abrdn World Healthcare Fund engaged KPMG LLP as its auditor.
“On September 7, 2023, upon the recommendation of the Audit Committee of the Board, the Board approved the engagement of KPMG LLP (“KPMG”) as the independent registered public accounting firm for the Fund for the fiscal year ending September 30, 2023.”
Deloitte & Touche LLP resigned as auditor of abrdn World Healthcare Fund.
“(a) Resignation of independent registered public accounting firm On September 6, 2023, Deloitte & Touche LLP (“D&T”), the independent registered public accounting firm for the Tekla World Healthcare Fund (the “Fund”), resigned due to an anticipated independence issue arising as a result of a pending transaction between Tekla Capital Management LLC and abrdn Inc.”
abrdn World Healthcare Fund entered into Sub-Placement Agent Agreement with UBS Securities LLC valued at commission rate of up to 0.80% of gross sales proceeds (effective 2022-12-14).
“Foreside has entered into a sub-placement agent agreement, dated December 14, 2022 (the “Sub-Placement Agent Agreement”), with UBS Securities LLC (“UBS”) relating to the Common Shares to be offered under the Distribution Agreement. Pursuant to the Distribution Agreement, the Fund will compensate Foreside with respect to sales of Common Shares at a commission rate of 1.00% of the gross proceeds of the sale of Common Shares. Out of this commission, under the Sub-Placement Agent Agreement, Foreside will compensate UBS at a rate of up to 0.80% of the gross sales proceeds of the sale of the Common Shares sold by UBS.”
abrdn World Healthcare Fund entered into Distribution Agreement with Foreside Fund Services, LLC valued at up to $150,000,000 (effective 2022-12-14).
“Tekla World Healthcare Fund (NYSE: THW) (the “Fund”) has entered into a distribution agreement (the “Distribution Agreement”), dated December 14, 2022, with Foreside Fund Services, LLC (“Foreside”), pursuant to which the Fund may offer and sell common shares of beneficial interest, par value $0.01 per share (“Common Shares”) having an aggregate initial offering price of up to $150,000,000, from time to time, through Foreside as agent for the Fund for the offer and sale of Common Shares, in transactions deemed to be “at the market” as defined in Rule 415 under the Securities Act of 1933, as amended (the “Offering”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.